These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 18791075)

  • 21. The cognitive neuroscience of working memory: relevance to CNTRICS and schizophrenia.
    Barch DM; Smith E
    Biol Psychiatry; 2008 Jul; 64(1):11-7. PubMed ID: 18400207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain network dynamics during working memory are modulated by dopamine and diminished in schizophrenia.
    Braun U; Harneit A; Pergola G; Menara T; Schäfer A; Betzel RF; Zang Z; Schweiger JI; Zhang X; Schwarz K; Chen J; Blasi G; Bertolino A; Durstewitz D; Pasqualetti F; Schwarz E; Meyer-Lindenberg A; Bassett DS; Tost H
    Nat Commun; 2021 Jun; 12(1):3478. PubMed ID: 34108456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel Dopamine Therapeutics for Cognitive Deficits in Schizophrenia.
    Arnsten AF; Girgis RR; Gray DL; Mailman RB
    Biol Psychiatry; 2017 Jan; 81(1):67-77. PubMed ID: 26946382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Schizophrenic deficits: neuroleptics and the prefrontal cortex.
    Jobe TH; Harrow M; Martin EM; Whitfield HJ; Sands JR
    Schizophr Bull; 1994; 20(3):413-6; discussion 417-21. PubMed ID: 7973463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent evidence for dopamine abnormalities in schizophrenia.
    Abi-Dargham A
    Eur Psychiatry; 2002 Aug; 17 Suppl 4():341s-347s. PubMed ID: 23573603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Genetic and pharmacological effects on prefrontal cortical function in schizophrenia].
    Heinz A; Braus DF; Romero B; Gallinat J; Puls I; Juckel G; Weinberger DR
    Nervenarzt; 2004 Sep; 75(9):845-56. PubMed ID: 15372159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fronto-striatal hypoactivation during correct information retrieval in patients with schizophrenia: an fMRI study.
    Koch K; Wagner G; Nenadic I; Schachtzabel C; Schultz C; Roebel M; Reichenbach JR; Sauer H; Schlösser RG
    Neuroscience; 2008 Apr; 153(1):54-62. PubMed ID: 18359576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Executive functioning component mechanisms and schizophrenia.
    Kerns JG; Nuechterlein KH; Braver TS; Barch DM
    Biol Psychiatry; 2008 Jul; 64(1):26-33. PubMed ID: 18549874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Occupancy of dopamine D(1), D (2) and serotonin (2A) receptors in schizophrenic patients treated with flupentixol in comparison with risperidone and haloperidol.
    Reimold M; Solbach C; Noda S; Schaefer JE; Bartels M; Beneke M; Machulla HJ; Bares R; Glaser T; Wormstall H
    Psychopharmacology (Berl); 2007 Feb; 190(2):241-9. PubMed ID: 17111172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Schizophrenia: a psychobiological view].
    Rodríguez-Arias M; Aguilar MA; Espert R; Miñarro J
    Rev Neurol; 1996 Oct; 24(134):1210-20. PubMed ID: 8983716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopamine D1-like receptors and reward-related incentive learning.
    Beninger RJ; Miller R
    Neurosci Biobehav Rev; 1998 Mar; 22(2):335-45. PubMed ID: 9579323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antipsychotic drug mechanisms and neurotransmitter systems in schizophrenia.
    Reynolds GP
    Acta Psychiatr Scand Suppl; 1994; 380():36-40. PubMed ID: 7914046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Restoring GABAergic signaling and neuronal synchrony in schizophrenia.
    Akbarian S
    Am J Psychiatry; 2008 Dec; 165(12):1507-9. PubMed ID: 19047328
    [No Abstract]   [Full Text] [Related]  

  • 34. The prefrontal cortex: a target for antipsychotic drugs.
    Artigas F
    Acta Psychiatr Scand; 2010 Jan; 121(1):11-21. PubMed ID: 20059453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Neural Circuit Mechanism for the Involvements of Dopamine in Effort-Related Choices: Decay of Learned Values, Secondary Effects of Depletion, and Calculation of Temporal Difference Error.
    Morita K; Kato A
    eNeuro; 2018; 5(1):. PubMed ID: 29468191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The dopamine hypothesis of schizophrenia. New findings for an old theory].
    Heinz A
    Nervenarzt; 2000 Jan; 71(1):54-7. PubMed ID: 10695033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Value of brain imaging in assessment of cognitive symptoms. Cognitive and emotional impact of antipsychotic drug treatment]].
    Martinot JL; Peretti CS
    Encephale; 2006 Jan; 32 Pt 2():S3-5. PubMed ID: 16800076
    [No Abstract]   [Full Text] [Related]  

  • 38. Antipsychotic efficacy: relationship to optimal D2-receptor occupancy.
    Pani L; Pira L; Marchese G
    Eur Psychiatry; 2007 Jul; 22(5):267-75. PubMed ID: 17419008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine, the prefrontal cortex and schizophrenia.
    Knable MB; Weinberger DR
    J Psychopharmacol; 1997; 11(2):123-31. PubMed ID: 9208376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of severe axial tardive dystonia with clozapine: case report and hypothesis.
    Trugman JM; Leadbetter R; Zalis ME; Burgdorf RO; Wooten GF
    Mov Disord; 1994 Jul; 9(4):441-6. PubMed ID: 7969212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.